Eli Lilly -> Kelonia Therapeutics

Pharma giant Eli Lilly announced it is acquiring biotech startup Kelonia Therapeutics in a deal valued at up to $7 billion in cash. Kelonia is a developer of gene therapies with a particular focus on cancer treatment, leveraging AI-powered platforms for drug discovery.